Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
Raissa Bulaty Tauil,
No information about this author
Paula Takano Golono,
No information about this author
Enzo Pereira de Lima
No information about this author
et al.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(10), P. 1354 - 1354
Published: Oct. 10, 2024
Metabolic-Associated
Fatty
Liver
Disease
(MAFLD)
is
a
clinical-pathological
scenario
that
occurs
due
to
the
accumulation
of
triglycerides
in
hepatocytes
which
considered
significant
cause
liver
conditions
and
contributes
an
increased
risk
death
worldwide.
Even
though
possible
causes
MAFLD
can
involve
interaction
genetics,
hormones,
nutrition,
lifestyle
(diet
sedentary
lifestyle)
most
influential
factor
developing
this
condition.
Polyphenols
comprise
many
natural
chemical
compounds
be
helpful
managing
metabolic
diseases.
Therefore,
aim
review
was
investigate
impact
oxidative
stress,
inflammation,
mitochondrial
dysfunction,
role
polyphenols
MAFLD.
Some
reverse
part
damage
related
or
among
them
are
anthocyanin,
baicalin,
catechin,
curcumin,
chlorogenic
acid,
didymin,
epigallocatechin-3-gallate,
luteolin,
mangiferin,
puerarin,
punicalagin,
resveratrol,
silymarin.
These
have
actions
reducing
plasma
enzymes,
body
mass
index,
waist
circumference,
adipose
visceral
indices,
lipids,
glycated
hemoglobin,
insulin
resistance,
HOMA
index.
They
also
reduce
nuclear
factor-KB
(NF-KB),
interleukin
(IL)-1β,
IL-6,
tumor
necrosis
factor-α
(TNF-α),
blood
pressure,
fat
content,
steatosis
fibrosis.
On
other
hand,
they
improve
HDL-c,
adiponectin
levels,
fibrogenesis
markers.
results
show
promising
prevention
treatment
Language: Английский
Study on the Correlation between Tea and Diabetic Retinopathy
进欣 冉
No information about this author
Advances in Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
15(02), P. 790 - 797
Published: Jan. 1, 2025
Language: Английский
The global burden of blindness and vision loss caused by type 2 diabetes mellitus from 1990 to 2021 and projections to 2050: findings from global burden of disease 2021
Critical Public Health,
Journal Year:
2025,
Volume and Issue:
35(1)
Published: March 7, 2025
We
aimed
to
analyze
the
global
trends
in
burden
of
blindness
and
vision
loss
caused
by
type
2
diabetes
from
1990
2050.
Based
on
Global
Burden
Disease
Study
(GBD)
2021,
prevalence
years
lived
with
disability
(YLD)
were
analyzed
age,
sex,
socio-demographic
index
(SDI)
for
204
countries
territories
projections
future
2021
There
5694156
(4498190–7112643)
numbers
459976
(304429–661417)
YLDs
due
at
level
2021.
The
age-standardized
rate
was
65.7
(52.2–82),
YLD
5.3
(3.5–7.6)
all
which
exhibited
increasing
Regionally,
highest
observed
Central
Latin
America
(145.8,
116.7–179.6).
Nationally,
Palestine
(265.2,
203.7–339)
had
rate.
Compared
males,
rates
higher
females
Most
21
GBD
regions
upward
presented
females,
both
sexes
a
during
retrospective
30
years.
Enhancing
population
screening,
optimizing
treatment
strategies,
such
as
improving
retinal
screening
community-based
disease
education,
are
essential
release
burden,
particularly
high-risk
groups.
Language: Английский
Mechanism and Therapeutic Targets of Circulating Immune Cells in Diabetic Retinopathy
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
210, P. 107505 - 107505
Published: Nov. 14, 2024
Diabetic
retinopathy
(DR)
continues
to
be
the
leading
cause
of
preventable
vision
loss
among
working-aged
adults,
marked
by
immune
dysregulation
within
retinal
microenvironment.
Typically,
retina
is
considered
as
an
immune-privileged
organ,
where
circulating
cells
are
restricted
from
entry
under
normal
conditions.
However,
during
progression
DR,
this
privilege
compromised
breach
barrier
and
infiltrate
retina.
Increasing
evidence
suggests
that
vascular
neuronal
degeneration
in
DR
largely
driven
infiltration
cells,
particularly
neutrophils,
monocyte-derived
macrophages,
lymphocytes.
This
review
delves
into
mechanisms
therapeutic
targets
associated
with
these
cell
populations
offering
a
promising
innovative
approach
managing
disease.
Language: Английский